statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its second quarter 2024 financial results before the market opens on Wednesday, July 31, 2024. A press release...

Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today

United Therapeutics: Strong Buy on Tyvaso's Promising IPF Treatment Prospects

Joseph Thome, an analyst from TD Cowen, maintained the Buy rating on United Therapeutics (UTHR Research Report). The associated price target is...

United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced full enrollment of the TETON 2 study evaluating the use of Tyvaso (treprostinil) inhalation solution (nebulized...

Unveiling 6 Analyst Insights On United Therapeutics

Latest Ratings for UTHR
 DateFirmActionFromTo Feb 2022WedbushMaintainsOutperform Feb 2022Ladenburg ThalmannMaintainsBuy Feb 2022BTIGInitiates Coverage OnNeutral
 View More Analyst Ratings for...

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the addition of former Minnesota Commissioner of Health Jan Malcolm to its Board of Directors. Ms. Malcolm was...

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update...

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2024. Total revenues in the first quarter of 2024...

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American...

Martine A. Rothblatt Sells 15,000 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock

United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) CEO Martine A. Rothblatt sold 15,000 shares of the company's stock in a transaction that occurred on Thursday, April 4th. The shares were sold...

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Volume	290,258.00
52-Wk High	$343.98
52-Wk Low	$208.62

UTHR United Therapeutics Corp

About

Feed

News

Sentiment

Earnings

Fundamentals